Mark Kubler - 18 Mar 2026 Form 3 Insider Report for InflaRx N.V. (IFRX)

Role: Director
Signature: /s/ Christian Schmid, Attorney-in-Fact
Issuer symbol: IFRX
Transactions as of: 18 Mar 2026
Net transactions value: $0
Form type: 3
Filing time: 18 Mar 2026, 08:16:35 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Kubler Mark	Director	C/O INFLARX N.V., WINZERLAER STREET 2, JENA, GERMANY	/s/ Christian Schmid, Attorney-in-Fact	18 Mar 2026	0002061697

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	IFRX	Ordinary Shares						960,015	18 Mar 2026	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	IFRX	Stock Option (Right to Buy)							18 Mar 2026	Ordinary Shares	7,308	$0.0131	Direct	F1
holding	IFRX	Stock Option (Right to Buy)							18 Mar 2026	Ordinary Shares	34,464	$1.86	Direct	F2
holding	IFRX	Stock Option (Right to Buy)							18 Mar 2026	Ordinary Shares	20,000	$1.86	Direct	F3
holding	IFRX	Stock Option (Right to Buy)							18 Mar 2026	Ordinary Shares	6,400	$1.86	Direct	F4
holding	IFRX	Stock Option (Right to Buy)							18 Mar 2026	Ordinary Shares	30,000	$1.86	Direct	F5
holding	IFRX	Stock Option (Right to Buy)							18 Mar 2026	Ordinary Shares	30,000	$2.37	Direct	F6
holding	IFRX	Stock Option (Right to Buy)							18 Mar 2026	Ordinary Shares	30,000	$1.79	Direct	F7
holding	IFRX	Stock Option (Right to Buy)							18 Mar 2026	Ordinary Shares	30,000	$2.41	Direct	F8
holding	IFRX	Stock Option (Right to Buy)							18 Mar 2026	Ordinary Shares	30,000	$1.17	Direct	F9

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted on July 21, 2016 and is fully vested and exercisable as of the date hereof.
F2	This option was granted on December 13, 2017 and is fully vested and exercisable as of the date hereof.
F3	This option was granted on January 4, 2021 and is fully vested and exercisable as of the date hereof.
F4	This option was granted on July 2, 2021 and is fully vested and exercisable as of the date hereof.
F5	This option was granted on January 12, 2022 and is fully vested and exercisable as of the date hereof.
F6	This option was granted on January 24, 2023 and is fully vested and exercisable as of the date hereof.
F7	This option was granted on January 5, 2024 and is fully vested and exercisable as of the date hereof.
F8	This option was granted on January 3, 2025 and is fully vested and exercisable as of the date hereof.
F9	This option was granted on January 6, 2026 and will vest and become exercisable in four equal installments of 7,500 shares on each quarterly anniversary of such grant date, subject to continued service through such dates.

Remarks:

Exhibit List - Exhibit 24.1 Power of Attorney